In dynamic high-tech industries such as the pharmaceutical sector, occasional innovations are not enough to survive in the market. Companies must continuously innovate, which requires a strong capacity for innovation and the appropriate design of research and development (R&D) as the main organizational area responsible for innovations. However, innovation capacity is a diffuse phenomenon, the fundamental aspects and organizational prerequisites of which are often inadequately or even tautologically addressed in academia. Heidi Günther addresses these issues by linking modern innovation and organizational research while taking into account the company's orientation tasks in the form of organizational learning and knowledge management. As a theoretical-conceptual basis, she develops innovation capacity in e.